Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Cellular and Physiological Nutrition/Metabolism

Clinical and Translational Nutrition

Session: Hepatic Ketone Production as the Governing Factor in Determining Fatty Liver and Type 2 Diabetes

MRS and Mass Spectrometry: Windows into the Inner Workings of Metabolic Disease

Monday, July 1, 2024

10:00 AM – 10:25 AM CT

Location: W375E

Speaker(s)

Gerald I. Shulman, MD, PhD, MACP, MACE, FRCP

George R. Cowgill Professor of Medicine and Cellular and Molecular Physiology
Yale School of Medicine
New Haven, Connecticut, United States

Disclosure(s): Aro Biotherapeutics: Consultant (Ongoing)
Arrowhead Pharmaceuticals: Speaker/Speaker's Bureau (Terminated, December 18, 2023)
AstraZeneca: Consultant (Terminated); Grant/Research Support (Terminated)
Bayer AG: Consultant (Ongoing)
Betagenon AB: Consultant (Ongoing)
DiCerna Pharmaceuticals, Inc.: Consultant (Ongoing)
Equator Therapeutics: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
Esperion Therapeutics: Consultant (Ongoing)
Eternygen GmbH: Consultant (Terminated, January 1, 2024)
Fortress Biotech: Consultant (Ongoing)
Generian Pharmaceuticals: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
iMetabolic Biopharma Corporation: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
Janssen: Consultant (Terminated, January 1, 2024); Speaker/Speaker's Bureau (Terminated, January 1, 2024)
Kriya Therapeutics,: Consultant (Ongoing)
Levels Health: Stock Shareholder (excluding mutual funds) (Ongoing)
Mammoth BioSciences, Inc: Consultant (Ongoing)
Maze Therapeutics, Inc.: Consultant (Terminated, January 1, 2023); Grant/Research Support (Terminated, January 1, 2023)
Merck Pharmaceuticals: Consultant (Ongoing); Grant/Research Support (Ongoing)
Novo Nordisk: Consultant (Ongoing)
OrsoBio: Stock Shareholder (excluding mutual funds) (Ongoing)